On ٠٦ نوفمبر ٢٠٢٥, XRAY reported earnings of 0.37 USD per share (EPS) for Q3 25, missing the estimate of 0.45 USD, resulting in a -19.04% surprise. Revenue reached 904.00 مليون, compared to an expected 914.64 مليون, with a -1.16% difference. The market reacted with a -12.68% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 المحللين forecast an EPS of 0.28 USD, with revenue projected to reach 945.06 مليون USD, implying an نقصان of -24.32% EPS, and زيادة of 4.54% in Revenue from the last quarter.